Last Updated: September 28, 2026

Litigation Details for Sotera Wireless, Inc. (Bankr. S.D. Cal. 2016)

✉ Email this page to a colleague

« Back to Dashboard

Sotera Wireless, Inc. (Bankr. S.D. Cal. 2016)

Docket	16-05968	Date Filed	2016-09-30
Court	United States Bankruptcy Court, S.D. California	Date Terminated	2018-07-19
Cause		Assigned To	Laura S. Taylor
Jury Demand		Referred To
Parties	UNITED STATES TRUSTEE
Patents	6,656,482
Attorneys	Jonathan Shenson
Firms	Foley and Lardner LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Sotera Wireless, Inc.

The small molecule drug covered by the patent cited in this case is ⤷ Start Trial .

Details for Sotera Wireless, Inc. (Bankr. S.D. Cal. 2016)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2016-09-30				External link to document
2016-09-30	11	Declaration in Support	10 Preferred Stock outstanding, 6,656,482 shares of Series D Preferred Stock …determined to be patentable but patents have not yet issued) 4 U.S. patents, along with 55…factors. The nominal patent term expirations on the U.S. 10 patents range from 2028 – 2030…applications and registrations, 12 patents, patent applications and like protections, trademarks…information. As 4 a result, Sotera’s patented, FDA 510(k)-cleared ViSi significantly improves	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.